Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-08-23 Sale |
2021-08-25 4:14 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
27,139 | $152.01 | $4,125,416 | 1,001,858 (Indirect Direct) |
View |
| 2021-08-19 Sale |
2021-08-20 6:14 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
22,682 | $151.28 | $3,431,398 | 1,028,997 (Indirect Direct) |
View |
| 2021-08-09 Sale |
2021-08-11 4:50 pm |
Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP, Chief Medical Officer |
2,400 | $164.05 | $393,720 | 198,391 (Direct) |
View |
| 2021-08-04 Sale |
2021-08-06 6:19 pm |
Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP, Chief Scientific Officer |
26,000 | $138.24 | $3,594,357 | 111,391 (Direct) |
View |
| 2021-08-05 Sale |
2021-08-06 6:17 pm |
Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer |
20,000 | $151.05 | $3,021,056 | 70,000 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 09:48 am |
Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director |
553,376 | $132.73 | $73,448,879 | 10,000 (Indirect) |
View |
| 2021-06-11 Sale |
2021-06-15 09:51 am |
Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director |
201,725 | $87.04 | $17,558,774 | 563,376 (Indirect) |
View |
| 2021-04-29 Sale |
2021-04-30 8:55 pm |
Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director |
4,513 | $85.43 | $385,546 | 765,101 (Indirect) |
View |
| 2021-04-26 Sale |
2021-04-28 7:51 pm |
Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director |
342,962 | $85.96 | $29,482,338 | 769,614 (Indirect) |
View |
| 2021-04-05 Sale |
2021-04-07 2:14 pm |
Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director |
800 | $84.98 | $67,984 | 1,112,576 (Indirect) |
View |
| 2021-04-05 Sale |
2021-04-06 6:09 pm |
Intellia Therapeutics Inc. | NTLA | DORSA CAROLINE Director |
7,500 | $82.19 | $616,405 | 14,498 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-02 8:46 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
38,209 | $83.64 | $3,195,661 | 1,180,742 (Indirect Direct) |
View |
| 2021-04-01 Sale |
2021-04-02 8:42 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
50,455 | $82.46 | $4,160,559 | 549,804 (Indirect Direct) |
View |
| 2021-02-26 Sale |
2021-03-01 1:59 pm |
Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director |
501,945 | $60.29 | $30,262,716 | 1,113,376 (Indirect) |
View |
| 2021-02-09 Sale |
2021-02-09 8:38 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
11,489 | $75 | $861,675 | 430,220 (Indirect Direct) |
View |
| 2021-02-05 Sale |
2021-02-09 8:36 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
50,985 | $71.7 | $3,655,410 | 1,072,920 (Indirect Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 9:39 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
177,745 | $67.26 | $11,955,395 | 1,198,892 (Indirect Direct) |
View |
| 2021-02-01 Sale |
2021-02-03 9:38 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
54,659 | $63.99 | $3,497,902 | 542,736 (Indirect Direct) |
View |
| 2021-01-05 Sale |
2021-01-05 9:24 pm |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
6,239 | $55.86 | $348,511 | 577,028 (Indirect Direct) |
View |
| 2021-01-05 Sale |
2021-01-05 8:58 pm |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
1,377 | $55.86 | $76,919 | 31,031 (Direct) |
View |
| 2021-01-05 Sale |
2021-01-05 8:55 pm |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
2,078 | $55.86 | $116,077 | 328,575 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-08-23 Exercise |
2021-08-25 4:14 pm |
N/A 2030-03-01 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
27,139 | $0 | 1,001,858 (Direct) |
View |
| 2021-08-23 Exercise |
2021-08-25 4:14 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
27,139 | $13.4 | 1,001,858 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-20 6:14 pm |
N/A 2030-03-01 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
22,682 | $0 | 1,028,997 (Direct) |
View |
| 2021-08-19 Exercise |
2021-08-20 6:14 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
22,682 | $13.4 | 1,028,997 (Direct) |
View |
| 2021-08-09 Exercise |
2021-08-11 4:50 pm |
N/A 2030-05-04 |
Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP, Chief Medical Officer |
2,400 | $0 | 198,391 (Direct) |
View |
| 2021-08-09 Exercise |
2021-08-11 4:50 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP, Chief Medical Officer |
2,400 | $12.62 | 198,391 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 6:19 pm |
N/A 2030-03-01 |
Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP, Chief Scientific Officer |
26,000 | $0 | 111,391 (Direct) |
View |
| 2021-08-04 Exercise |
2021-08-06 6:19 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP, Chief Scientific Officer |
26,000 | $13.4 | 111,391 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-06 6:17 pm |
N/A 2028-10-31 |
Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer |
20,000 | $0 | 70,000 (Direct) |
View |
| 2021-08-05 Exercise |
2021-08-06 6:17 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer |
20,000 | $19.27 | 70,000 (Direct) |
View |
| 2021-07-01 Option Award |
2021-07-06 4:44 pm |
N/A 2031-06-30 |
Intellia Therapeutics Inc. | NTLA | BASTA JAMES EVP, General Counsel |
130,000 | $0 | 130,000 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 6:14 pm |
N/A 2031-06-22 |
Intellia Therapeutics Inc. | NTLA | Verwiel Frank Director |
5,476 | $0 | 5,476 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 6:10 pm |
N/A 2031-06-22 |
Intellia Therapeutics Inc. | NTLA | Keresty Georgia Director |
5,476 | $0 | 5,476 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 6:08 pm |
N/A 2031-06-22 |
Intellia Therapeutics Inc. | NTLA | GOODMAN JESSE Director |
5,476 | $0 | 43,476 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 6:05 pm |
N/A 2031-06-22 |
Intellia Therapeutics Inc. | NTLA | FORMELA JEAN FRANCOIS Director |
5,476 | $0 | 5,476 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 6:03 pm |
N/A 2031-06-22 |
Intellia Therapeutics Inc. | NTLA | DORSA CAROLINE Director |
5,476 | $0 | 5,476 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:57 pm |
N/A 2031-06-22 |
Intellia Therapeutics Inc. | NTLA | Crowley John F Director |
5,476 | $0 | 5,476 (Direct) |
View |
| 2021-06-23 Option Award |
2021-06-25 5:56 pm |
N/A 2031-06-22 |
Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director |
5,476 | $0 | 5,476 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 8:50 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
25,937 | $0 | 803,657 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 8:50 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
15,937 | $13.88 | 803,657 (Direct) |
View |
| 2021-04-13 Exercise |
2021-04-15 8:50 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
10,000 | $6.83 | 803,657 (Direct) |
View |
| 2021-04-09 Option Award |
2021-04-13 4:37 pm |
N/A 2031-04-08 |
Intellia Therapeutics Inc. | NTLA | Keresty Georgia Director |
12,710 | $0 | 12,710 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-06 6:09 pm |
N/A 2025-12-21 |
Intellia Therapeutics Inc. | NTLA | DORSA CAROLINE Director |
7,500 | $0 | 14,498 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-06 6:09 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | DORSA CAROLINE Director |
7,500 | $6.4 | 14,498 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 8:46 pm |
N/A 2028-12-17 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
71,041 | $0 | 1,180,742 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 8:46 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
26,041 | $13.4 | 1,180,742 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 8:46 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
45,000 | $14.58 | 1,180,742 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 8:42 pm |
N/A 2027-01-05 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
97,001 | $0 | 549,804 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 8:42 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
21,000 | $18.3 | 549,804 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 8:42 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
33,000 | $13.88 | 549,804 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 8:42 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $14.58 | 549,804 (Direct) |
View |
| 2021-04-01 Exercise |
2021-04-02 8:42 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
33,001 | $6.83 | 549,804 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 5:54 pm |
N/A 2031-03-02 |
Intellia Therapeutics Inc. | NTLA | Sepp-Lorenzino Laura EVP, Chief Scientific Officer |
98,000 | $0 | 98,000 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 5:53 pm |
N/A 2031-03-02 |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
91,875 | $0 | 91,875 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 5:52 pm |
N/A 2031-03-02 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
85,750 | $0 | 85,750 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 5:50 pm |
N/A 2031-03-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
219,757 | $0 | 219,757 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 5:49 pm |
N/A 2031-03-02 |
Intellia Therapeutics Inc. | NTLA | Lebwohl David EVP, Chief Medical Officer |
89,250 | $0 | 89,250 (Direct) |
View |
| 2021-03-03 Option Award |
2021-03-05 5:49 pm |
N/A 2031-03-02 |
Intellia Therapeutics Inc. | NTLA | Goddard Glenn EVP, Chief Financial Officer |
85,750 | $0 | 85,750 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-09 8:38 pm |
N/A 2027-12-11 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
21,000 | $0 | 430,220 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-09 8:38 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
21,000 | $18.3 | 430,220 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 8:36 pm |
N/A 2030-03-01 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
96,718 | $0 | 1,072,920 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 8:36 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
40,000 | $13.4 | 1,072,920 (Direct) |
View |
| 2021-02-09 Exercise |
2021-02-09 8:36 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
56,718 | $6.83 | 1,072,920 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:39 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
317,060 | $0 | 1,198,892 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:39 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
30,000 | $18.3 | 1,198,892 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:39 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
77,060 | $13.88 | 1,198,892 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:39 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
110,000 | $22.78 | 1,198,892 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:39 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
100,000 | $6.83 | 1,198,892 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:38 pm |
N/A 2026-02-02 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
109,000 | $0 | 542,736 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:38 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
33,000 | $13.88 | 542,736 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:38 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
10,000 | $14.58 | 542,736 (Direct) |
View |
| 2021-02-01 Exercise |
2021-02-03 9:38 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
66,000 | $6.83 | 542,736 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-22 4:22 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director |
20,000 | $13.78 | 48,000 (Direct) |
View |
| 2021-01-20 Exercise |
2021-01-22 4:22 pm |
N/A 2029-01-22 |
Intellia Therapeutics Inc. | NTLA | Cohen Fred E Director |
20,000 | $0 | 48,000 (Direct) |
View |
| 2020-12-31 Exercise |
2021-01-05 9:24 pm |
2020-12-31 N/A |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
14,375 | $0 | 577,028 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 9:24 pm |
2020-12-31 2028-03-20 |
Intellia Therapeutics Inc. | NTLA | LEONARD JOHN M President and CEO |
43,125 | $0 | 577,028 (Direct) |
View |
| 2020-12-31 Exercise |
2021-01-05 8:58 pm |
2020-12-31 N/A |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
4,792 | $0 | 31,031 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 8:58 pm |
2020-12-31 2028-03-20 |
Intellia Therapeutics Inc. | NTLA | SCHIERMEIER ANDREW EVP, Chief Operating Officer |
14,375 | $0 | 31,031 (Direct) |
View |
| 2020-12-31 Exercise |
2021-01-05 8:55 pm |
2020-12-31 N/A |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
4,792 | $0 | 328,575 (Direct) |
View |
| 2020-12-31 Option Award |
2021-01-05 8:55 pm |
2020-12-31 2028-03-20 |
Intellia Therapeutics Inc. | NTLA | Rivera Jose E EVP, General Counsel |
14,375 | $0 | 328,575 (Direct) |
View |